A Long-Term Examination of Asthma From Childhood Through Adolescence
NCT ID: NCT00541255
Last Updated: 2023-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1313 participants
OBSERVATIONAL
2007-09-30
2015-02-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Study of Asthma From Birth to Adulthood
NCT00005475
Prospective Study of Dietary Factors, BMI, and Risk of Asthma in Children
NCT00454415
Community Based Study of Adult Onset Asthma
NCT00005544
Epidemiology of Pediatric Asthma Hospitalization
NCT00005445
Follow-up of Children With Severe Asthma at Adult Age
NCT05032209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At previous study visits that occurred when participants were 1, 2, 4, and 10 years old, information on the following was collected: asthma and other allergic diseases, family history of asthma, and early life risk factors, including breastfeeding and tobacco smoke exposure. A blood sample was collected at participants' 10-year study visit. For this current study, all 18-year-old participants will return for a study visit. Participants will complete questionnaires on asthma and allergy symptoms and environmental exposures, including tobacco smoke and pollution. Blood collection, an allergy skin prick test, lung function testing, and a bronchial challenge test to assess airway function will occur. Select participants will also have a sputum sample collected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
17 Years
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Isle of Wight NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor S Hasan Arshad
Chair in Allergy and Clinical Immunology, University of Southampton and Hon. Consultant Physician, University Hospital Southampton Director, The David Hide Asthma and Allergy Research Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Syed Arshad, MD
Role: PRINCIPAL_INVESTIGATOR
University of Southampton, United Kingdom
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The David Hide Asthma and Allergy Research Centre
Newport, Isle Of Wight, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Click here for The David Hide Asthma and Allergy Research Centre Web site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.